Literature DB >> 22510519

N-acetyl-L-cysteine inhibits marble-burying behavior in mice.

Nobuaki Egashira1, Atsunori Shirakawa, Moe Abe, Tomiko Niki, Kenichi Mishima, Katsunori Iwasaki, Ryozo Oishi, Michihiro Fujiwara.   

Abstract

In the present study, we examined the effect of N-acetyl-L-cysteine (NAC), a glutamate-modulating agent, on marble-burying behavior in mice. Fluvoxamine (30 mg/kg, p.o.) and mirtazapine (3 mg/kg, i.p.) significantly inhibited marble-burying behavior without affecting locomotor activity. Similarity, NAC (150 mg/kg, i.p.) significantly inhibited marble-burying behavior without affecting locomotor activity. On the other hand, the antioxidant α-tocopherol (10, 30, and 100 mg/kg, p.o.) had no effect on the marble-burying behavior. These results suggest that the glutamatergic system is involved in the marble-burying behavior, and NAC may be useful for treatment of OCD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510519     DOI: 10.1254/jphs.11228sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  6 in total

Review 1.  A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.

Authors:  Geoffrey de Brouwer; Arina Fick; Brian H Harvey; De Wet Wolmarans
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

2.  N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review.

Authors:  Georgina Oliver; Olivia Dean; David Camfield; Scott Blair-West; Chee Ng; Michael Berk; Jerome Sarris
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

3.  Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.

Authors:  Mohammadrasoul Khalkhali; Setareh Aram; Homa Zarrabi; Moosa Kafie; Abtin Heidarzadeh
Journal:  Iran J Psychiatry       Date:  2016-04

Review 4.  Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review.

Authors:  Patrícia Santos; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

Review 5.  The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.

Authors:  Richard C J Bradlow; Michael Berk; Peter W Kalivas; Sudie E Back; Richard A Kanaan
Journal:  CNS Drugs       Date:  2022-03-22       Impact factor: 6.497

6.  Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome.

Authors:  Lukas Marius Bühner; Sampath K T Kapanaiah; Dennis Kätzel
Journal:  Front Behav Neurosci       Date:  2022-09-26       Impact factor: 3.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.